Comparing chest PNF and chest mobility exercises for university students who smoke
Official title: Comparison of the Effects of Chest PNF Techniques and Chest Mobility Exercises on Respiratory Function, Chest Expansion, and Functional Capacity in University Students With Smoking Addiction: A Single-Blind Randomized Controlled Study
Run by University of Yalova · NCT07488741 · Data updated 2026-11-12
This trial tries two chest exercise programs to see if they help 18–24-year-old university students who smoke breathe better and improve lung function.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 24 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of Yalova Academic / other |
| Locations | 1 site (Yalova, Yalova) |
| Status | Recruiting |
| Started | March 9, 2026 |
| Main results expected | October 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | March 25, 2026 |
| Trial ID | NCT07488741 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
University students aged 18–24 who have smoked for at least two years, smoke at least five cigarettes per day with a Fagerström score ≥4, have FEV1 ≥80%, and can perform exercise are ideal candidates.
✕Probably not a fit
People with COPD or asthma, recent cardiac or lung surgery, orthopedic or neurological conditions that limit exercise, or those who do not meet the smoking or lung-function criteria are unlikely to receive benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
At Yalova University, volunteers aged 18–24 who smoke will be assigned to either a chest PNF (proprioceptive neuromuscular facilitation) techniques group or a general chest mobility exercises group. The interventions focus on increasing thoracic mobility and respiratory muscle function using active and passive chest maneuvers. Measurements such as FVC, FEV1, chest expansion, and other physiological respiratory parameters will be recorded before and after the intervention. Participants must meet smoking, nicotine-dependence, and lung-function criteria and have no orthopedic or neurological barriers to exercise.
Why it matters
Potential benefit: If successful, these exercises could increase chest expansion, improve lung volumes, and reduce breathlessness during exercise for young smokers.
How similar studies have gone: Previous smaller studies of chest PNF and mobility exercises have reported improvements in lung function and chest expansion, so the approach has some supportive evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age of 18-24 years * Fagerström Nicotine Dependence Questionnaire score ≥4 * Smoking for at least 2 years * Daily smoking ≥5 cigarettes and at least 90 pack-years. Stable condition (no acute respiratory infection in the last 4 weeks). * FEV1 ≥80% * Voluntary participation in the study * No orthopedic or neurological problems that would prevent participation in exercise Exclusion Criteria: * Cardiac event or lung surgery in the last 6 months * Respiratory problems such as COPD, asthma * Orthopedic and neurological problems * Termination of volunteering
Where it's running
-
Yalova University
Yalova, Yalova, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Büşra KAYABINAR, PhD — University of Yalova
- Study coordinator: Gözde ARICA, MSc
- Email: gozde.arica@yalova.edu.tr
- Phone: +905318893236
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Salivary IL-8 and Serum IL-6 as Biomarkers to Distinguish Oral Premalignant Disorders in Smokers and Never-Smokers
This study tests whether salivary IL-8 and blood IL-6 can help tell apart adults with oral premalignant conditions from those with healthy mouths, and whether smoking influences these markers.
-
Access to multiple tobacco flavors to help adult cigarette smokers quit using e-cigarettes
This study tests whether giving adult smokers an e-cigarette with a choice of flavors helps them quit smoking by the end of 13 weeks.
-
Smoking, MFN1, and NLRP3 Levels in Gum Fluid Across Periodontal Health and Disease
This study tests whether smoking changes MFN1 and NLRP3 protein levels in the fluid around the gums for adults with or without periodontitis.
-
Heated tobacco access and cigarette quitting among adult smokers
This study tests whether giving adult smokers access to a heated tobacco product helps them quit smoking by the end of 3 months.
-
How flavors of ENDS might help adults quit smoking their usual cigarettes
This study tests whether giving adults who smoke their regular cigarettes an electronic nicotine delivery system with different flavors can help them quit smoking their usual cigarettes after 3 months.
-
Periodontal status, smoking, and salivary inflammasome markers
This trial will test whether levels of salivary inflammasome proteins (NLRP-3, NLRP-6, NLRP-12, NLRC-5, IL-1β and IL-10) differ between people with and without periodontitis and whether smoking changes those levels.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.